PI
SRNE

Putnam Investments’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Putnam Investments’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-115,877
Closed -$568K – 1300
2016
Q4 		$568K Sell
115,877
-168,659
-59% -$1.01M ﹤0.01% 1105
2016
Q3 		$2.2M Buy
284,536
+72,675
+34% +$489K 0.01% 818
2016
Q2 		$1.19M Hold
211,861
– – ﹤0.01% 1076
2016
Q1 		$1.14M Buy
211,861
+757
+0.4% +$4.4K ﹤0.01% 1083
2015
Q4 		$1.84M Hold
211,104
– – ﹤0.01% 998
2015
Q3 		$1.77M Buy
+211,104
New +$3.36M ﹤0.01% 1022

Other funds holding SRNE

WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return